These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 12755599)
21. Folding and binding integrity of variants of a prototype ligand-binding module from the LDL receptor possessing multiple alanine substitutions. Abdul-Aziz D; Fisher C; Beglova N; Blacklow SC Biochemistry; 2005 Apr; 44(13):5075-85. PubMed ID: 15794645 [TBL] [Abstract][Full Text] [Related]
22. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662 [TBL] [Abstract][Full Text] [Related]
23. Solution structure of the tumor necrosis factor receptor-1 death domain. Sukits SF; Lin LL; Hsu S; Malakian K; Powers R; Xu GY J Mol Biol; 2001 Jul; 310(4):895-906. PubMed ID: 11453696 [TBL] [Abstract][Full Text] [Related]
24. Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature. Jones MD; Hunt J; Liu JL; Patterson SD; Kohno T; Lu HS Biochemistry; 1997 Dec; 36(48):14914-23. PubMed ID: 9398215 [TBL] [Abstract][Full Text] [Related]
25. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. Ni CZ; Oganesyan G; Welsh K; Zhu X; Reed JC; Satterthwait AC; Cheng G; Ely KR J Immunol; 2004 Dec; 173(12):7394-400. PubMed ID: 15585864 [TBL] [Abstract][Full Text] [Related]
26. Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis. Borysenko CW; Furey WF; Blair HC Biochem Biophys Res Commun; 2005 Mar; 328(3):794-9. PubMed ID: 15694416 [TBL] [Abstract][Full Text] [Related]
27. Specificity of molecular recognition learned from the crystal structures of TRAIL and the TRAIL:sDR5 complex. Cha SS; Song YL; Oh BH Vitam Horm; 2004; 67():1-17. PubMed ID: 15110168 [TBL] [Abstract][Full Text] [Related]
28. Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Cachero TG; Schwartz IM; Qian F; Day ES; Bossen C; Ingold K; Tardivel A; Krushinskie D; Eldredge J; Silvian L; Lugovskoy A; Farrington GK; Strauch K; Schneider P; Whitty A Biochemistry; 2006 Feb; 45(7):2006-13. PubMed ID: 16475789 [TBL] [Abstract][Full Text] [Related]
29. BAFF, APRIL and their receptors: structure, function and signaling. Bossen C; Schneider P Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324 [TBL] [Abstract][Full Text] [Related]
30. An APRIL to remember: novel TNF ligands as therapeutic targets. Dillon SR; Gross JA; Ansell SM; Novak AJ Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316 [TBL] [Abstract][Full Text] [Related]
31. BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1. Kanakaraj P; Migone TS; Nardelli B; Ullrich S; Li Y; Olsen HS; Salcedo TW; Kaufman T; Cochrane E; Gan Y; Hilbert DM; Giri J Cytokine; 2001 Jan; 13(1):25-31. PubMed ID: 11145839 [TBL] [Abstract][Full Text] [Related]
32. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Schiemann B; Gommerman JL; Vora K; Cachero TG; Shulga-Morskaya S; Dobles M; Frew E; Scott ML Science; 2001 Sep; 293(5537):2111-4. PubMed ID: 11509691 [TBL] [Abstract][Full Text] [Related]
33. BAFF costimulation of Toll-like receptor-activated B-1 cells. Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Starling GC; Kiener PA; Aruffo A; Bajorath J Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690 [TBL] [Abstract][Full Text] [Related]
35. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. Cao P; Mei JJ; Diao ZY; Zhang Sq Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238 [TBL] [Abstract][Full Text] [Related]
37. The biochemistry and biology of BAFF, APRIL and their receptors. Kalled SL; Ambrose C; Hsu YM Curr Dir Autoimmun; 2005; 8():206-42. PubMed ID: 15564723 [TBL] [Abstract][Full Text] [Related]
38. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution. Guan ZB; Shui Y; Zhang SQ Cytokine; 2007 Sep; 39(3):192-200. PubMed ID: 17822916 [TBL] [Abstract][Full Text] [Related]
39. BAFF AND APRIL: a tutorial on B cell survival. Mackay F; Schneider P; Rennert P; Browning J Annu Rev Immunol; 2003; 21():231-64. PubMed ID: 12427767 [TBL] [Abstract][Full Text] [Related]